Ahren Innovation Capital is the famous VC, which was founded in 2017. The main department of described VC is located in the Cambridge. The fund was located in Europe if to be more exact in United Kingdom.
We also calculated 1 valuable employee in our database.
The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Medical Device, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Cambridge Epigenetix, Mogrify, Bicycle Therapeutics.
The top activity for fund was in 2019. This Ahren Innovation Capital works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2019. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Ahren Innovation Capital, startups are often financed by SV Health Investors, SR One, Syncona Partners LLP. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures, Cambridge Innovation Capital, 24 Haymarket. In the next rounds fund is usually obtained by Vertex Ventures, University of Bristol Enterprise Fund, Tybourne.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Bohemian Companies | Colorado, Fort Collins, United States |
| Color Capital | Oregon, Portland, United States |
| Expansion Capital | Latvia, Riga, Riga |
| Fininvest | Italy, Lazio, Rome |
| Fusion LA | California, Santa Monica, United States |
| Guardian Life Insurance Company - Dental Service Organization | New York, New York, United States |
| Long March Investment Fund | - |
| Madison Wells Media | California, Los Angeles, United States |
| OST | New York, New York, United States |
| Peter Crosby Trust | - |
| Purpose Ventures | Czechia, Prague, Prague |
| Shanghai Changjingpai Investment Center | - |
| Shanghai Jinyi Keji Touzi Youxian Gongsi | China, Chongming, Chongming District |
| Shuangliang Capital | - |
| Singha Ventures | Bangkok, Krung Thep, Thailand |
| Slottsbacken | Stockholm, Stockholm County, Sweden |
| TM Service Technology Holdings | - |
| Transcend Fund | - |
| Xingye Venture Capital | China, Minghang, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nu Quantum | $9M | 02 Nov 2023 | Cambridge, England, United Kingdom | ||
Mogrify | $10M | 02 Oct 2023 | Cambridge, England, United Kingdom | ||
ZOE | $30M | 01 Dec 2022 | Boston, Massachusetts, United States | ||
Ambi Robotics | $32M | 17 Oct 2022 | Berkeley, California, United States | ||
Constructive Bio | $15M | 15 Aug 2022 | Essex, England, United Kingdom | ||
Phaidra | $25M | 15 Jul 2022 | Seattle, Washington, United States | ||
AI21 Labs | $64M | 12 Jul 2022 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Bitfount | $5M | 12 May 2022 | London, England, United Kingdom | ||
Heirloom | $53M | 17 Mar 2022 | San Francisco, California, United States |
– Edifice Health is a San Mateo, CA-based immunological health and personalized nutrition company.
– Company raised $12m in Series A funding led by Leaps by Bayer with participation from Paladin Capital Group, Vertical Venture Partners, Ahren Innovation Capital, Ataraxia Capital Partners, Shanda Grab Ventures, Alafi Capital, and Taisho Pharmaceutical.
– The funds will be used to grow its foundation of immunological science and add additional talent.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nu Quantum | $9M | 02 Nov 2023 | Cambridge, England, United Kingdom | ||
Mogrify | $10M | 02 Oct 2023 | Cambridge, England, United Kingdom | ||
ZOE | $30M | 01 Dec 2022 | Boston, Massachusetts, United States | ||
Ambi Robotics | $32M | 17 Oct 2022 | Berkeley, California, United States | ||
Constructive Bio | $15M | 15 Aug 2022 | Essex, England, United Kingdom | ||
Phaidra | $25M | 15 Jul 2022 | Seattle, Washington, United States | ||
AI21 Labs | $64M | 12 Jul 2022 | Tel Aviv-Yafo, Tel Aviv District, Israel | ||
Bitfount | $5M | 12 May 2022 | London, England, United Kingdom | ||
Heirloom | $53M | 17 Mar 2022 | San Francisco, California, United States |
